Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-23 · accession 0000950170-24-047645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-24 | 2024-04-23 | CATX | Austin Mark John | VP Fin, Prin Fin, Acct Offic | M - OptEx | $0.36 | +30.0K | 84.0K | +56% | +$10.8K |
| D | 2024-04-24 | 2024-04-23 | CATX | Austin Mark John | VP Fin, Prin Fin, Acct Offic | M - OptEx | $0.00 | -30.0K | 120.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-04-23 | M | A | 30,000 | $0.36 | 84,030 | D | — | — | |
| 2 | Derivative | Stock option (right to buy) | 2024-04-23 | M | D | 30,000 | $0.00 | 120,000 | D | $0.36 · — to 2032-08-09 | 150,000 Common Stock | (F1) The Stock Option is fully vested. |